Journal Information
Statistics
Follow this link to access the full text of the article
Original article
Comparative effectiveness and drug survival of biosimilar infliximab CPT-13 vs. reference infliximab in inflammatory bowel disease: A retrospective cohort study
Comparación de efectividad y persistencia del infliximab biosimilar CPT-13 versus infliximab de referencia en la enfermedad inflamatoria intestinal: Un estudio de cohorte retrospectivo
Lidia Serrano Díaza,d, Carles Iniesta Navalónb,d,
, Rosa Gómez Espína,d, Isabel Nicolás De Pradoa,d, Enrique Bernal Morellc,d, Lorena Rentero Redondob
Corresponding author
a Department of Gastroenterology, Reina Sofia Hospital of Murcia, Spain
b Department of Hospital Pharmacy, Reina Sofia Hospital of Murcia, Spain
c Department of Infectious Disease, Reina Sofia Hospital of Murcia, Spain
d Biomedical Research Institute of Murcia (IMIB-Pascual Parrilla), University Clinical Hospital Virgen de la Arrixaca, Murcia, Spain